Bilophila sp.

Information

Microbe Identification

Bilophila sp.

Microbe id: PMDBM2020448
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Bilophila sp. [1929485]
Taxonomy Genus: Bilophila [35832]
Taxonomy Family: Desulfovibrionaceae [194924]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Bilophila sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Bilophila sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Bilophila sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Bilophila sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Bilophila sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗2.85009108792121mNGS
Kidney Failure, Chronic PRJNA449784🔗3.10778259291214mNGS
Hypertension PRJNA509999🔗2.93132303488611mNGS
Arthritis, Juvenile PRJNA562467🔗-3.3641758424197316S
Cushing Syndrome PRJNA923180🔗5.6515214872627516S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-3.3465145811052116S
Diarrhea PRJNA317326🔗3.1348409685573816S
Diarrhea PRJEB14038🔗3.20811752526671mNGS
Colorectal Neoplasms PRJEB53415🔗2.7662966644908716S
Colorectal Neoplasms PRJNA936589🔗2.93134830132427mNGS
Colorectal Neoplasms PRJDB11845🔗3.3288955490960816S
Colorectal Neoplasms PRJNA763023🔗3.41088393631461mNGS
Colorectal Neoplasms PRJNA731589🔗3.63935653643881mNGS
Respiratory Syncytial Virus Infections PRJNA579491🔗-3.0091300025054216S
Tuberculosis, Gastrointestinal PRJNA743795🔗-3.5858681475865716S
Gastrointestinal Diseases PRJNA917086🔗-3.7855390990087116S
Hepatitis, Autoimmune PRJNA556801🔗-3.6303858978276116S
Parkinson Disease PRJNA588035🔗3.23718026974435mNGS
Parkinson Disease PRJNA742875🔗3.4130223745348716S
Colitis, Ulcerative PRJNA917086🔗-3.8882697887573816S
Colitis, Ulcerative PRJNA429990🔗-3.44601113605421mNGS
Colitis, Ulcerative PRJNA813736🔗-2.87631513694045mNGS
Colitis, Ulcerative PRJNA398089🔗-2.53558636708652mNGS
Colitis, Ulcerative PRJNA993675🔗2.43619200673807mNGS
Colitis, Ulcerative PRJNA820056🔗2.9334189535611816S
Hepatitis B, Chronic PRJNA872871🔗-3.6329998137492316S
Spondylarthritis PRJNA342486🔗-3.4738561265285116S
Caliciviridae Infections PRJNA788674🔗-3.2467749560675816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.1952267875142516S
Asthma PRJEB23348🔗-2.8831220769562716S
Crohn Disease PRJNA917086🔗-3.8230677837383316S
Crohn Disease PRJEB76677🔗-3.44061607679624mNGS
Crohn Disease PRJNA398089🔗-2.32057754144648mNGS
Crohn Disease PRJNA820056🔗3.0564330231922316S
Psoriasis PRJNA938297🔗-2.08254854558826mNGS
Psoriasis PRJNA634145🔗3.23147366361411mNGS
Polycystic Ovary Syndrome PRJEB38647🔗3.6138757891287116S
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗-3.4704787282282216S
Appendicitis PRJDB8606🔗4.0040515537223616S
Diabetic Retinopathy PRJNA857030🔗3.7107537242517616S
Arthritis, Rheumatoid PRJNA786110🔗-3.6561750519610616S
Cholangiocarcinoma PRJNA932948🔗-3.17021064255299mNGS
Neuroblastoma PRJEB63351🔗3.00049967941396mNGS
Hematologic Neoplasms PRJNA777832🔗3.1709931999915816S
Graves Ophthalmopathy PRJNA1089481🔗-3.7284942493837916S
Myasthenia Gravis PRJNA688881🔗-3.04965288732294mNGS
Irritable Bowel Syndrome PRJNA705217🔗-2.85168869000033mNGS
Gastroesophageal Reflux PRJNA993632🔗3.45449590844492mNGS
Clostridium Infections PRJNA648321🔗4.01875056253937mNGS
Pancreatic Neoplasms PRJNA665854🔗2.93004942241742mNGS
Cholelithiasis PRJNA999028🔗-3.11079928414899mNGS
Fatty Liver, Alcoholic PRJNA690835🔗-3.4085025844196816S
Liver Cirrhosis PRJNA872871🔗-3.77860532748816S
Cystic Fibrosis PRJNA314903🔗2.41765330426446mNGS
Obesity PRJNA1125836🔗-3.39216269493961mNGS
Neuromyelitis Optica PRJNA662563🔗4.0384215911257816S
Inflammatory Bowel Diseases PRJNA993675🔗-2.92430187440486mNGS
Inflammatory Bowel Diseases PRJEB13266🔗-2.8040914002672516S
Renal Insufficiency, Chronic PRJNA949558🔗-3.5803457177632216S
Renal Insufficiency, Chronic PRJEB65297🔗3.09105213732356mNGS
COVID-19 PRJNA769052🔗-3.6475908299846616S
COVID-19 PRJDB13214🔗2.57742419245117mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Bilophila sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Bilophila sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Bilophila sp.

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Bilophila_sp_4_1_30 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Bilophila sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Bilophila sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Bilophila sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Bilophila sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Bilophila sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found!

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Bilophila sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Bilophila sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Bilophila sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?